Related Experiment Video
Updated: Aug 8, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in
K V Sitz1, L D Loomis-Price, S Ratto-Kim
1Division of Retrovirology, Walter Reed Army Institute of Research, and Henry M. Jackson Foundation, Rockville, Maryland, USA.
Insights
Mapping human immunodeficiency virus type 1 (HIV-1) CD4 T cell epitopes in vivo using a delayed-type hypersensitivity assay offers a simpler method for studying immune responses. This technique aids HIV-1 research and vaccine development.
Area of Science:
- Immunology
- Virology
- Dermatology
Background:
- Studying in vivo cellular immune responses to human immunodeficiency virus type 1 (HIV-1) is challenging in large patient groups due to technical limitations.
- Understanding CD4 T lymphocyte epitopes is crucial for assessing immune regulation in HIV-1 infection.
Purpose of the Study:
- To map CD4 T lymphocyte epitopes of HIV-1 using a simple in vivo method.
- To correlate in vivo findings with previously identified in vitro epitopes.
- To assess the utility of this technique for large-scale patient studies and HIV vaccine development.
Main Methods:
- Utilized small peptide fragments of the HIV-1 gp120 third variable loop.
- Employed a cutaneous delayed-type hypersensitivity (DTH) assay to map epitopes in vivo.
- Compared DTH responses with in vitro epitope mapping data from CD4 T lymphocyte lines.
Main Results:
- Successfully mapped CD4 T lymphocyte epitopes in two HIV-1 infected individuals using the DTH assay.
- Demonstrated a correlation between in vivo DTH responses and previously identified in vitro epitopes.
- Validated the feasibility of using DTH assay for in vivo epitope mapping.
Conclusions:
- The cutaneous delayed-type hypersensitivity (DTH) assay provides a practical in vivo method for mapping CD4 T lymphocyte epitopes in HIV-1 infection.
- This technique can yield valuable diagnostic and prognostic information on HIV-1 immunoregulation.
- The method holds significant potential for HIV vaccine development and studying other immune-mediated diseases.
Abstract:
Cellular immune responses to human immunodeficiency virus type 1 (HIV-1) infection, particularly in vivo responses, have been difficult to study in large patient cohorts because of technical impediments. By use of small peptide fragments of the HIV-1 gp120 third variable loop, the CD4 T lymphocyte epitopes of 2 HIV-infected persons were mapped using a cutaneous delayed-type hypersensitivity (DTH) assay. The in vivo DTH responses correlated with epitopes previously identified in vitro using CD4 T lymphocyte lines. The ability to determine CD4 T lymphocyte epitopes in large cohorts of patients using this simple in vivo technique would provide important diagnostic and prognostic data regarding effective immunoregulation of HIV-1. This technique should have broad applicability in HIV vaccine development and in the investigation of other immune-mediated human diseases.
